DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial 

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial  ; volume:25 ; number:1 ; day:26 ; month:1 ; year:2024 ; pages:1-17 ; date:12.2024
Trials ; 25, Heft 1 (26.1.2024), 1-17, 12.2024

Creator
Nampota-Nkomba, Nginache
Nyirenda, Osward M.
Mallewa, Jane
Chimalizeni, Yamikani
Dzabala, Nettie
Fay, Michael P.
Gopalakrishnan, Mathangi
Laurens, Matthew B.
O’Brien, Nicole F.
Miller, Louis H.
Pierce, Susan K.
Riggle, Brittany A.
Postels, Douglas G.
Contributor
SpringerLink (Online service)

DOI
10.1186/s13063-023-07808-w
URN
urn:nbn:de:101:1-2024040811191574260018
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Nampota-Nkomba, Nginache
  • Nyirenda, Osward M.
  • Mallewa, Jane
  • Chimalizeni, Yamikani
  • Dzabala, Nettie
  • Fay, Michael P.
  • Gopalakrishnan, Mathangi
  • Laurens, Matthew B.
  • O’Brien, Nicole F.
  • Miller, Louis H.
  • Pierce, Susan K.
  • Riggle, Brittany A.
  • Postels, Douglas G.
  • SpringerLink (Online service)

Other Objects (12)

Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study

Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study

Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress

Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress

A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits

A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial

Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial

What does a modified-Fibonacci dose-escalation actually correspond to?

What does a modified-Fibonacci dose-escalation actually correspond to?

Phase I dose-escalation oncology trials with sequential multiple schedules

Phase I dose-escalation oncology trials with sequential multiple schedules

PK/PD modeling supports the dose-escalation decision in VIKING

PK/PD modeling supports the dose-escalation decision in VIKING

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study

Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia

Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia

A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia

A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

Related objects